BM
Bristol-Myers Squibb
BMY · NYSE
$66.83 -1.85% (-$1.26)
1M +3.24%
Market Cap $139.1B
P/E Ratio 14.98x
Div. Yield 3.69%
ROE 46.75%
Bulios Fair Price
$96.48
44.4% upside
Trenutna cena
$66.83
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BMY trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
75 /100
Cheap P/E 14.98x
EV/EBITDA 10.41x
P/S 2.83x
Growth
31 /100
Declining EPS growth 5.36%
Rev. growth 1.45%
FCF growth 2.44%
Profitability
100 /100
Strong Gross margin 70.16%
Net margin 18.87%
Op. margin 28.27%
Quality
83 /100
Excellent ROIC 15.47%
ROE 46.75%
ROA 10.59%
Debt
54 /100
Moderate Debt/Equity 1.93x
Current ratio 1.53x
Int. coverage 7.88x
Stability
35 /100
Moderate Beta 0.23x
Rev. volatility 5.14%
EPS volatility 198.26%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BMY
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Christopher Boerner
Employees
32,500
Headquarters
Princeton
Prihajajoči dogodki
29 OKT.
Earnings
Upcoming earnings report